AstraZeneca Pleads Guilty in Criminal Cancer Medicine Scheme Sun, 22 Jun 2003 AstraZeneca agreed to a $355 million settlement in civil and criminal charges. Government prosecutors found that AstraZeneca reported to the government that the average wholesale price for a monthly dose of the prostate cancer drug, Zoladex, was about…
The Crawford Resignation Mystery Sat, 24 Sep 2005 Merrill Goozner of Center for Science in the Public Interest provides insight into what may lie behind the sudden resignation of FDA Commissioner, Lester Crawford. Goozner surggests, “One possible clue to the administration’s thinking comes from the appointment of Andrew von Eschenbach,…
Comprehensive scientific review concluded: All pesticides pose serious health risks to humans–especially children Sat, 8 May 2004 The Ontario College of Family Physicians (“the voice of family medicine in Ontario”) conducted an exhaustive review of the medical/scientific pesticide literature from around the world (1990–2003) on the health effects of commonly…
Sen Grassley Expands Investigation – Why did FDA approve Vioxx for Children??? Mon, 18 Oct 2004 The Financial Times of London and The Washington Post report that the Senate Finance Committee is expanding its probe of the FDA and its cosy relationship with drug manufacturers. The Vioxx debacle is but…
An illuminating essay by Byron Richards, author of Fight for Your Health: Exposing the FDA’s Betrayal of America, should be required reading for every member of Congress before voting Yes or NO on the appointment of Dr. Andrew von Eschenbach, who is poised to head the FDA.
Bush’s Choice for F.D.A. Chief to Keep Other Job Mon, 26 Sep 2005 President Bush proposes to appoint Dr. von Eschenbach to head the FDA while at the same time maintaining his “day job” as head of the National Cancer Institute. Clearly the administration thinks very little about the importance…
Abbott Seeks FDA approval for cancer drug despite failed trials – WSJ Mon, 12 Sep 2005 Abbott Laboratories is asking the FDA to approve a cancer drug even though it failed in clinical trials to demonstrate a benefit greater than placebo–which is a minimal FDA requirement. The Wall Street Journal…
Death & Other Problems at Fargo VA Research Detroit_BNA Mon, 21 Apr 2003 Medical research at the Department of Veterans Affairs appears to be in disarray–veterans’ lives are at serious risk in an environment that does not take seriously federal safety requirements. It is apparent that during its tenure as…
Class Action Lawsuit Filed Following Deaths at VA_Albany Thu, 20 Mar 2003 A class action lawsuit has been filed on March 18, 2003 in U.S. District Court(NY), by attorney Alan Milstein, on behalf of “all persons who participated in human subject experiments” conducted by defendants, oncologist Dr. James Holland and…
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 9, 2002 Debate on Value of ScreeningTests for Cancer FYI Today’s Science section in The New York Timesprovides the kind of critical reporting that has not…
